← Eichor
Condition: Intracranial Glioma Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Intracranial Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Phase 1/Phase 2 · 1 location(s) · University of Miami · NCT05956821
A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in
Phase 1 · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06097975
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2
Phase 1 · 5 location(s) · Johann Wolfgang Goethe University Hospital · NCT03383978
Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Phase 2 · 1 location(s) · Marzieh Ebrahimi · NCT06687681
Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors
NA · 3 location(s) · Emory University · NCT04908709
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgi
EARLY_Phase 1 · 1 location(s) · Eben Rosenthal · NCT07493447
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
Phase N/A · 1 location(s) · Medical University of Warsaw · NCT07411690
F-Tryptophan PET/CT in Human Cancers
Phase 1 · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT05556473
Study of How Safe and Effective Tarlatamab is in Brain Cancers
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06776250
Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
NA · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06747728
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05555550
Brain Glioma Registry Combining Clinical and Imaging Information
Phase N/A · 1 location(s) · Asan Medical Center · NCT02619890
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05968053
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progress
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06815029
18F-Fluciclovine PET-MRI in High-grade Glioma
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05553041
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Phase 2 · 1 location(s) · Emory University · NCT06132685
Study of GC101 TIL in Brain Glioma (Soochow2)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT04943913
AI-driven Processing and Analysis of Glioma Imaging Data
Phase N/A · 1 location(s) · Università degli Studi di Trento · NCT07703761
Preoperative Proton Irradiation for High-grade Brain Gliomas.
Phase 1 · 1 location(s) · National Medical Research Radiological Centre of the Ministr · NCT07710040
ABY-029 Glioma Trial
Phase 1 · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT07063693
Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transde
NA · 1 location(s) · Medical University of Warsaw · NCT07413796
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection
Phase 1/Phase 2 · 1 location(s) · Dushu Lake Hospital Affiliated to Soochow University · NCT06018363
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.